RLY-1971
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Solid Tumor, Unspecified, Adult
Conditions
Solid Tumor, Unspecified, Adult
Trial Timeline
Feb 4, 2020 → Nov 22, 2022
NCT ID
NCT04252339About RLY-1971
RLY-1971 is a phase 1 stage product being developed by Roche for Solid Tumor, Unspecified, Adult. The current trial status is completed. This product is registered under clinical trial identifier NCT04252339. Target conditions include Solid Tumor, Unspecified, Adult.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04252339 | Phase 1 | Completed |
Competing Products
20 competing products in Solid Tumor, Unspecified, Adult